AU3930600A - Methods for identifying agents that inhibit serum aging factors and uses and compositions thereof - Google Patents

Methods for identifying agents that inhibit serum aging factors and uses and compositions thereof

Info

Publication number
AU3930600A
AU3930600A AU39306/00A AU3930600A AU3930600A AU 3930600 A AU3930600 A AU 3930600A AU 39306/00 A AU39306/00 A AU 39306/00A AU 3930600 A AU3930600 A AU 3930600A AU 3930600 A AU3930600 A AU 3930600A
Authority
AU
Australia
Prior art keywords
compositions
methods
identifying agents
aging factors
inhibit serum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU39306/00A
Inventor
D. James Morre
Dorothy M Morre
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Purdue Research Foundation
Original Assignee
Purdue Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Purdue Research Foundation filed Critical Purdue Research Foundation
Publication of AU3930600A publication Critical patent/AU3930600A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU39306/00A 1999-03-30 2000-03-29 Methods for identifying agents that inhibit serum aging factors and uses and compositions thereof Abandoned AU3930600A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12689499P 1999-03-30 1999-03-30
US60126894 1999-03-30
PCT/US2000/008433 WO2000057871A2 (en) 1999-03-30 2000-03-29 Methods for identifying agents that inhibit serum aging factors and uses and compositions thereof

Publications (1)

Publication Number Publication Date
AU3930600A true AU3930600A (en) 2000-10-16

Family

ID=22427252

Family Applications (1)

Application Number Title Priority Date Filing Date
AU39306/00A Abandoned AU3930600A (en) 1999-03-30 2000-03-29 Methods for identifying agents that inhibit serum aging factors and uses and compositions thereof

Country Status (2)

Country Link
AU (1) AU3930600A (en)
WO (1) WO2000057871A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1307281B1 (en) * 1999-11-25 2001-10-30 Simonelli Giuseppe USE OF UBICHINONE Q10 FOR LOCAL TREATMENT AND PREVENTION OF OPHTHALMOLOGICAL DYPATALOGIES SECONDARY TO PHOTOREFRACTIVE THERAPY,
TWI329513B (en) * 2001-10-12 2010-09-01 Kaneka Corp Use of reduced coenzyme q for lessening oxidative stress
ITRM20010755A1 (en) 2001-12-20 2003-06-20 Simonelli Giuseppe USE OF Q10 QUINONE FOR THE TREATMENT OF EYE DISEASES.
US7345018B2 (en) 2002-04-25 2008-03-18 Reception Aps Method of treating side effects induced by therapeutic agents
TWI322008B (en) * 2003-01-31 2010-03-21 Kaneka Corp Fatigue improving agent including reduced coenzyme q10
WO2005034945A1 (en) * 2003-10-11 2005-04-21 Thierry Schwitzguebel Use of norphenazone and coenzyme q for curing arthrose, arthritis and osteoarthritis
TW200524579A (en) * 2003-11-28 2005-08-01 Kaneka Corp Composition for protecting liver functions
US20050226947A1 (en) * 2004-02-04 2005-10-13 Dale Kern Agents for sequestering serum aging factors and uses therefore
WO2006104154A1 (en) * 2005-03-29 2006-10-05 Kaneka Corporation Composition for enhancing expression and activity of protease in liver
WO2009120217A1 (en) * 2008-03-28 2009-10-01 Nu Skin International, Inc. Cosmetic compositions for the inhibition of reactive oxygen species
US20120207862A1 (en) * 2010-09-02 2012-08-16 Morre D James ORAL INHIBITORS OF AGE-RELATED NADH OXIDASE (arNOX), COMPOSITIONS AND NATURAL SOURCES
MA52274A (en) * 2017-05-17 2021-02-24 Berg Llc USE OF COENZYME Q10 FORMULATIONS IN THE TREATMENT AND PREVENTION OF BUBBLE EPIDERMOLYSIS

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4056613A (en) * 1975-07-21 1977-11-01 Societa Farmaceutici Italia S.P.A. Method of reducing the cardiotoxic side effects of glycosidic anthracyclinones
IT1290907B1 (en) * 1997-01-31 1998-12-14 Idi Farmaceutici Spa COMPOSITION BY DIET PRODUCT EFFECTIVE IN COMBATING OXIDATIVE STRESS AND CELL DECAY.
ATE201988T1 (en) * 1997-02-11 2001-06-15 Mse Pharmazeutika Gmbh TRANSDERMAL, ORAL AND INTRAVENOUS PREPARATIONS OF 2,3-DIMETHOXY-5-METHYL-6-DECAPRENYL-1,4-BENZOCINONE
WO1998035658A2 (en) * 1997-02-12 1998-08-20 Mse Pharmazeutika Gmbh The use of 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4-benzoquinone
FR2763850B1 (en) * 1997-06-02 2000-02-18 Slow Age Creations USE OF AN UBIQUINONE IN ASSOCIATION WITH A TOCOPHEROL AND A POLYPHENOL FOR THE TREATMENT OF AGING SKIN

Also Published As

Publication number Publication date
WO2000057871A2 (en) 2000-10-05
WO2000057871A3 (en) 2002-01-31

Similar Documents

Publication Publication Date Title
AU3905399A (en) Methods and compositions for transgene identification
AU1314800A (en) Thio-modified aptamer synthetic methods and compositions
AU5898599A (en) Methods and compositions for genomic modification
AU2001263155A1 (en) Methods and compositions for interaction trap assays
AUPQ419099A0 (en) Novel compositions and methods
AU4322999A (en) Methods and compositions for diagnosing tauopathies
AU2001271720A1 (en) Methods and compositions for determining gene function
AU2349399A (en) R-lansoprazole compositions and methods
AU2030000A (en) Methods and compositions for identifying receptor effectors
AU3669199A (en) Methods of identifying and using hla binding compounds as hla-agonists and antagonists
AU5565099A (en) Pharmaceutical compositions and methods for use
AU5781800A (en) Methods and compositions for assaying analytes
AU3930600A (en) Methods for identifying agents that inhibit serum aging factors and uses and compositions thereof
AU4577999A (en) Methods and compositions for inhibiting corrosion
AU7685798A (en) Compositions and methods for preventing adhesion
AU3020899A (en) Compositions and methods for protein secretion
AU2970299A (en) Compositions and methods for polynucleotide delivery
AU1740500A (en) Thyroid peroxidase autoantibody assay compositions, method and kit
EP1207896A4 (en) Methods and compositions for reducing serum phosphate levels
AU1113499A (en) Compositions and methods for identifying and testing therapeutics against hsv infection
AU3511900A (en) Bovine pregnancy testing
AUPO982097A0 (en) Methods and compositions for use therein
AU5394200A (en) Method and kit for ligand assay
AU2565100A (en) Methods and compositions using binding partners
AU2880699A (en) Pharmaceutical compositions and methods for use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase